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, Introduction
Micro-RNAs (miRNAs) were defined as small endogenous
non-coding RNAs consisting of 18-24 nucleotides,
responsible for the gene expression and involved in many
cellular processes (Figure 1). The expression of the
enzyme plasminogen activator inhibitor-1 (PAI-1), the
main modulator of thrombosis, fibrinolysis,
inflammation, angiogenesis and atherogenesis, encoded
by SERPINE-1 locus, has been recently discovered to be
inhibited or stimulated by different miRNAs [1]. The
exact role of miRNA as biomarkers and treatment targets
of fibrinolysis disorders remains the subject of
continuous research.
Purpose
To study the literature data regarding the
role of miRNA in the processes of
fibrinolysis for identifying the possible
diagnostic and therapeutic strategies.
Material and methods
There were analyzed: Wiley Online library,
Crossref, Google Scholar databases, using the
combination of the terms “miRNA in
fibrinolysis”, “regulation of plasminogen




A number of miRNAs were suggested both as potential biomarkers
for the diagnosis of thrombotic disorders, and as a treatment
perspective for venous thrombosis.
Bibliography
1. Iwaki T., Urano T., Umemura K. PAI-1, progress in under-standing the clinical problem and its aetiology. Br J 
Haematol 2012; 157: 291–8.
2. Teruel‐Montoya R., Rosendaal F. R., Martínez C. MicroRNAs in hemostasis. J Thromb Haemost 2015; 13: 170–
81.
3. Morelli V.M., Braekkan S. K., Hansen J. Role of microRNAs in Venous Thromboembolism. Int. J. Mol. Sci. 2020, 
21(7), 2602; https://doi.org/10.3390/ijms21072602
4. Marchand A., Proust C., Morange P.E., et al. miR-421 and miR-30c inhibit SERPINE 1 gene expression in human 
endothelial cells. PLoS One 2012; 7:e44532.
5. Jiang Z., Ma J., Wang Q., et al. Combination of circulating miRNA-320a/b and D-dimer improves diagnostic 
accuracy in deep vein thrombosis patients. Med. Sci. Monit. 2018, 24, 2031–2037.
6. Kong L., Hu N., Du, X., et al. Upregulation of miR-483-3p contributes to endothelial progenitor cells 
dysfunction in deep vein thrombosis patients via SRF. J. Transl. Med. 2016, 14, 23. 
7. Wang W., Zhu X., Du X., et al. MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells 
in deep venous thrombosis by targeting SRCIN1. Microvasc. Res. 2019, 123, 35–41. 
8. Du X., Hong L., Sun L., et al. miR-21 induces endothelial progenitor cells proliferation and angiogenesis via 
targeting FASLG and is a potential prognostic marker in deep venous thrombosis. J. Transl. Med. 2019, 17, 270.
Keywords
fibrinolysis, miRNA.
miRNAs activity The effect 
descovered
miR-421 and miR-30c, by 
exerting direct inhibition in 
the 3-UTR of SERPINE-1 
mRNA
Inhibition of PAI-1 
in human umbilical 
vein enothelial cell 
(HUVECs)  and 
pulmonary 
endothelial cells [4]
Serum elevation of miR-
320a, miR-320b, miR-424-











Figure 1. Micro-RNA (miRNA) 
mechanisms of target regulation [2]
Figure 2. Micro-RNAs reported to regulate 
coagulation and fibrinolysis pathways [3] 
Table 1. miRNAs as biomarkers 
and treatment targets
